Skip to main content
. 2022 May-Jun;67(3):311. doi: 10.4103/ijd.ijd_745_21

Table 1.

CAM use according to demographic characteristics and disease involvement

History of CAM use Overall P

Present Absent



n % n % n %
Age
 Mean 21.42±7.56 21.50±5.6 21.44±7.12 0.771
Gender
 Female 898 78.70 243 21.30 1141 72.60 0.000
 Male 271 63.00 159 37.00 430 27.40
Marital status
 Married 85 67.50 41 32.50 126 8.00 0.064
 Single 1082 75.00 361 25.00 1443 92.00
Education level
 None, literate, primary school, middle school 89 70.10 38 29.90 127 8.10 0.475
 High school, college 470 74.50 161 25.50 631 40.40
 Undergraduate, postgraduate 605 75.20 200 24.80 805 51.50
Income level*
 300$ and below 174 74.00 61 26.00 235 15.30 0.102
 300-650$ 533 76.70 162 23.30 695 45.20
 650-1,300$ 332 72.80 124 27.20 456 29.70
 above 1,300$ 102 67.50 49 32.50 151 9.80
Acne severity classification according to FDA
 Group 1 140 64.80 76 35.20 216 13.90 0.003
 Group 2 422 73.80 150 26.20 572 36.70
 Group 3 404 77.50 117 22.50 521 33.40
 Group 4 193 77.20 57 22.80 250 16.00
CADI score
 Mean 7.65±3.8 6.66±4.12 7.39±4.05 0.000
Disease duration (months)
 Mean 53.7±39.7 53.91±48.45 53.75±42.07 0.058
Smoking status
 Non-smoker 903 76.00 285 24.00 1188 83.60 0.035
 Smoker 172 73.80 61 26.20 233 16.40
Smoking pack years 1.64±11.17 1.2±2.98 1.51±9.95 0.035
Alcohol consumption
 None 954 75.20 315 24.80 1269 80.90 0.013
 Regular 10 47.60 11 52.40 21 1.30
 Social 203 72.80 76 27.20 279 17.80
Family history of AV
 Absent 593 75.50 192 24.50 785 50.00 0.305
 Present 576 73.30 210 26.70 786 50.00
 Present 47 71.20 19 28.80 66 4.20

CADI, Cardiff Acne Disability Index. FDA, Food and Drug Administration CAM, Complementary and Alternative Medicine. *Income level was calculated based on the exchange rate at the time of the study